Skip to main content Skip to main navigation Skip to search Skip to footer

"Unlike a CIO at a true start-up, which has a clean technology slate from which to build efficient IT systems, I inherited an eclectic mix of technology infrastructures that somehow had to be melded into a cohesive, state-of-the-art IT organization." –

Virgina Guthrie, former CIO, Dr Pepper Snapple Group (talking of the IT and Operations Simplification Program she ran at Dr Pepper)

Virgina Guthrie, former CIO, Dr Pepper Snapple Group (talking of the IT and Operations Simplification Program she ran at Dr Pepper)

 
 

THINK CARE @ LAUNCH – INVERT THE PRODUCT LIFECYCLE FOR SUCCESS IN A PATIENT-CENTRIC FUTURE

The life sciences industry is undergoing a period of flux. Changes in commercial effectiveness, pipeline and growth prospects, regulatory, legal and compliance effects, payer influence, and increased focus on the patient are the key factors driving the search for change in the industry. Effectively dealing with these opportunities requires collaboration with all sides—regulatory, provider and Pharmaceutical to put the patient at the center.

How this will change almost everything in the commercialization space of a medicinal product’s lifecycle; and how we, at HCL Technologies, think this change should be dealt with are the topics that are covered in this paper.

  • Technology creating new opportunities for life sciences companies
  • Need for pharmaceutical companies to rethink their approach to patient care
  • Think Care @ Launch: A new approach for patient-centric product lifecycle management
  • Nexus of Forces Adoption in Life Sciences Drives Competitive Advantage – Gartner report

Who will find this report useful?

CFO, CMO, CMIO, CIO, Clinical Analytics, Patient Engagement, Strategy & Innovation, Claims Operations

Industry: Lifescience and Healthcare

Contact Us
MAX CHARACTERS: 10,000

We will treat any information you submit with us as confidential. Please read our privacy statement for additional information.

We will treat any information you submit with us as confidential. Please read our privacy statement for additional information.